What's Shaking: Monday's Early Movers

Apple - Investors will be watching to see if Apple shares exceed the $500 mark, after they rose as high as $497.62 on Friday. Meanwhile, The company is asking a federal court in California to prohibit the sale of Samsung’s Galaxy Nexus smartphones. Apple claims the phone infringes its patents, the latest salvo in a worldwide patent dispute involving the two companies.

Motorola Mobility , Google - European Union regulators reportedly set to approve Google’s $12.5 billion takeover of Motorola Mobility with no additional conditions attached. The Justice Department is also expected to give its OK for the transaction this week.

News Corp. - Several several senior staff members at the Sun newspaper have been arrested in an ongoing corruption probe.

ITT - The company has postponed its earnings release to February 29 from the original scheduled February 15 date. It did, however, release 2011 revenue numbers, which grew 11% to $2.1 billion, slightly below analyst estimates of $2.2 billion.

Watson Pharmaceuticals - The drug maker has filed a new drug application with the FDA to launch a generic version of Beyaz, an oral contraceptive made by Bayer HealthCare.

Sara Lee - The stock has been upgraded to "outperform" from "market perform" at Bernstein, with the price target upped to $24. The firm cites, among other things, improved profitability in the company's coffee business.

Estee Lauder - The stock has been downgraded to "neutral" from "buy" at Citi, which says higher investment spending may put pressure on earnings.

Regeneron Pharmaceuticals - The drugmaker lost 58 cents a share for its latest quarter, two cents smaller than estimated, though revenues did fall short of consensus. It also raised its 2012 U.S. sales forecast for its eye drug Eylea.

AmerisourceBergen - Chief Financial Officer Michael DiCandilo has left to "pursue other interests", according to a company press release. He'll be replaced on an interim basis by VP/Controller Tim Guttman.